Maximizing Pharmaceutical Patent Life Cycles Conference October 23-25 in New York City

American Conference Institute has announced that its seventh annual conference on Maximizing Pharmaceutical Patent Life Cycles will be taking place October 23-25, 2006, in New York.

According to ACI, the conference is designed specifically for pharmaceutical patent attorneys, and allows patent practitioners for brand name and generic drug makers to benchmark their companies’ current patent strategies and tactics against competitors in both camps.  ACI has assembled a distinguished faculty of leading in-house pharmaceutical counsel and expert attorneys for both brand names and generics, as well as government representatives who will share their knowledge and give critical insight on such topics as the CAFC’s findings on inequitable conduct, the link between patent life cycle management and patent portfolio management, Orange Book listing and delisting strategies, market exclusivities, the safe harbor, brand-name and generic settlements, and Supreme Court cases affecting pharmaceutical patents.

Other highlights include keynote addresses by the FDA and FTC.  There also will be Master Classes for brand names and generics on:

• New Strategies for Obtaining Pharmaceutical Patent Extensions; and
• Updated Drafting Guidelines for Paragraph IV Certifications and Notice Letters

According to ACI, demand for this conference is high and another sell-out is expected; early registrations are recommended.  For more information, visit the conference website.  Orange Book Blog is a media sponsor of this conference.